Methyl Alcohol

Methyl Alcohol

SCHEMBL910066

CCCCC(=O)C(=O)O.CO

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 7/20 0.68
CES2 O00748 6/20 0.68
CA1 P00915 1/20 0.52
HAO1 Q9UJM8 1/20 0.52
ALDH1A1 P00352 3/20 0.48
AKR1B1 P15121 1/20 0.48
TP53 P04637 1/20 0.48
PPARG P37231 4/20 0.46
PPARD Q03181 4/20 0.46
PPARA Q07869 4/20 0.46
TSHR P16473 3/20 0.46
GPR84 Q9NQS5 3/20 0.46
HDAC11 Q96DB2 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
SLC22A6 Q4U2R8 1/20 0.46
SLC22A8 Q8TCC7 1/20 0.46
TLR2 O60603 1/20 0.46
MEN1 O00255 1/20 0.46
ESR1 P03372 1/20 0.46
FABP4 P15090 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL60653 0.97
SCHEMBL21114376 0.97 CES1 (0.72) CES1CES2CA1HAO1ALDH1A1
SCHEMBL11586293 0.94 CES1 (0.68) CES1CES2CA1HAO1ALDH1A1
SCHEMBL11651642 0.94 CES1 (0.68) CES1CES2CA1HAO1ALDH1A1
Hydrochloric Acid SCHEMBL32662493 0.94 CES1 (0.68) CES1CES2CA1HAO1ALDH1A1
SCHEMBL28753518 0.94 CES1 (0.68) CES1CES2CA1HAO1ALDH1A1
SCHEMBL2681589 0.94 CES1 (0.68) CES1CES2CA1HAO1ALDH1A1
SCHEMBL19915214 0.94 CES1 (0.68) CES1CES2CA1HAO1ALDH1A1
Alcohol SCHEMBL910020 0.92 CES1 (0.65) CES1CES2CA1HAO1ALDH1A1
Methyl Alcohol SCHEMBL29172196 0.90 CES2 (0.71) CES1CES2HAO1ALDH1A1AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9487602-B2 Furan based resin, process for the preparation thereof, and use of the compound DSM IP ASSETS B.V. (NL) 2016-11-08 US claimed
US-20130109822-A1 FURAN BASED RESIN, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND DSM IP ASSETS B.V. (NL) 2013-05-02 US claimed
US-20110306735-A1 PROCESS FOR THE PREPARATION OF A HYDROXY-AROMATIC RESIN; HYDROXY-AROMATIC RESIN, AND MODIFICATION THEREOF DSM IP ASSETS B.V. (NL) 2011-12-15 US claimed
US-20110021740-A1 FURAN BASED RESIN, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND DSM IP ASSETS B.V. (NL) 2011-01-27 US claimed
EP-2222656-A1 FURAN BASED RESIN, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND DSM IP Assets B.V. (NL) 2010-09-01 EP claimed
US-20090203851-A1 Process for the Preparation of a Hydroxy-Aromatic Resin: Hydroxy-Aromatic Resin, and Modification Thereof DSM IP ASSETS B.V. (NL) 2009-08-13 US claimed
WO-2009077587-A1 FURAN BASED RESIN, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND DSM IP ASSETS B.V. (NL) 2009-06-25 WO claimed
EP-2024317-A2 PROCESS FOR THE PREPARATION OF A HYDROXY-AROMATIC RESIN; HYDROXY-AROMATIC RESIN, AND MODIFICATION THEREOF DSMIP Assets B.V. (NL) 2009-02-18 EP claimed
WO-2007140941-A2 PROCESS FOR THE PREPARATION OF A HYDROXY-AROMATIC RESIN; HYDROXY-AROMATIC RESIN, AND MODIFICATION THEREOF DSM IP ASSETS B.V. (NL) 2007-12-13 WO claimed
US-9487602-B2 Furan based resin, process for the preparation thereof, and use of the compound DSM IP ASSETS B.V. (NL) 2016-11-08 US disclosed
US-20130109822-A1 FURAN BASED RESIN, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND DSM IP ASSETS B.V. (NL) 2013-05-02 US disclosed
US-20110306735-A1 PROCESS FOR THE PREPARATION OF A HYDROXY-AROMATIC RESIN; HYDROXY-AROMATIC RESIN, AND MODIFICATION THEREOF DSM IP ASSETS B.V. (NL) 2011-12-15 US disclosed
US-20110112260-A1 COMPOSITION COMPRISING A BLEND OF RESINS DSM IP ASSETS B.V. (NL) 2011-05-12 US disclosed
US-20110086988-A1 COMPOSITION COMPRISING POLYOLS EVONIK DEGUSSA GMBH (DE) 2011-04-14 US disclosed
EP-1633472-A1 ENCAPSULATED MATERIALS DSM IP Assets B.V. (NL) 2006-03-15 EP disclosed
CN-1659152-A Nitrogen-containing compounds, their preparation and use in amino-aldehyde resins DSM IP ASSETS BV (NL) 2005-08-24 CN disclosed
US-20050176916-A1 Nitrogen-containing compound, the preparation thereof and application in amino-aldehyde resins DSM I.P. ASSETS B.V. (NL) 2005-08-11 US disclosed
EP-1507770-A2 NITROGEN-CONTAINING COMPOUND, THE PREPARATION THEREOF AND APPLICATION IN AMINO-ALDEHYDE RESINS DSM IP Assets B.V. (NL) 2005-02-23 EP disclosed
WO-2004110614-A1 ENCAPSULATED MATERIALS DSM IP ASSETS B.V. (NL) 2004-12-23 WO disclosed
WO-2003101973-A2 NITROGEN-CONTAINING COMPOUND, THE PREPARATION THEREOF AND APPLICATION IN AMINO-ALDEHYDE RESINS DSM IP ASSETS B.V. (NL) 2003-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203851-A1 Process for the Preparation of a Hydroxy-Aromatic Resin: Hydroxy-Aromatic Resin, and Modification Thereof HRH3, HRH1, C9 CES1 2109/4885CES2 973/4885CA1 4651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.